Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Pfizer announces topline phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity | Pfizer
( Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
for 10 min at 4 C to remove cell debris
Inhibition of cyclophilin Ametalloproteinase-9 pathway alleviates the development of neuropathic pain by promoting repair of the bloodspinal cord barrier
A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3
US$ 24.10
US$ 23.10
US$ 22.60
US$ 25.42
US$ 21.06
US$ 27.88
US$ 28.78
